#apalutamide api

Apalutamide API is the active pharmaceutical ingredient (API) used in the manufacture of Apalutamide, a prescription medication for the treatment of certain types of prostate cancer. Apalutamide is a type of drug called an androgen receptor (AR) inhibitor. AR inhibitors work by blocking the androgen receptor, which is a protein that plays a role in the growth and development of prostate cancer cells.

Apalutamide API is a white to off-white powder that is insoluble in water. It is typically manufactured using a multi-step chemical synthesis process. Once the API is manufactured, it is formulated into finished dosage forms such as tablets or capsules.

Apalutamide API is a potent drug substance, and its manufacture and use is subject to strict regulatory requirements. In the United States, Apalutamide API is manufactured by Janssen Pharmaceuticals, Inc.

Here are some additional details about Apalutamide API:

CAS number: 956104-40-8

Molecular formula: C23H27FN4O2

Molecular weight: 402.49 g/mol

Melting point: 190-194 °C

Solubility: Insoluble in water, soluble in organic solvents such as ethanol and acetone

Apalutamide API is a complex molecule, and its synthesis requires specialized equipment and expertise. It is important to note that Apalutamide API is a prescription drug, and it should only be used under the supervision of a qualified healthcare professional.

Apalutamide API is also available in amorphous and Form B crystalline forms. The amorphous form of Apalutamide API is more soluble in water than the Form B crystalline form, which makes it easier to formulate into finished dosage forms.